Vanguard Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $17.9B | Buy |
54,838,826
+961,975
| +2% | +$305M | 0.26% | 56 |
|
|
2025
Q3 | $15.2B | Buy |
53,876,851
+165,281
| +0.3% | +$47.9M | 0.23% | 69 |
|
|
2025
Q2 | $15B | Buy |
53,711,570
+841,117
| +2% | +$238M | 0.24% | 60 |
|
|
2025
Q1 | $16.5B | Buy |
52,870,453
+148,658
| +0.3% | +$43.9M | 0.3% | 48 |
|
|
2024
Q4 | $13.7B | Buy |
52,721,795
+339,522
| +0.6% | +$101M | 0.24% | 63 |
|
|
2024
Q3 | $16.9B | Buy |
52,382,273
+508,907
| +1% | +$166M | 0.3% | 46 |
|
|
2024
Q2 | $16.2B | Sell |
51,873,366
-214,844
| -0.4% | -$63.1M | 0.31% | 44 |
|
|
2024
Q1 | $14.8B | Buy |
52,088,210
+3,045,657
| +6% | +$891M | 0.29% | 52 |
|
|
2023
Q4 | $14.1B | Buy |
49,042,553
+6,572
| +0% | +$1.79M | 0.31% | 49 |
|
|
2023
Q3 | $13.2B | Buy |
49,035,981
+165,636
| +0.3% | +$41.3M | 0.32% | 47 |
|
|
2023
Q2 | $10.9B | Buy |
48,870,345
+40,885
| +0.1% | +$9.49M | 0.26% | 65 |
|
|
2023
Q1 | $11.8B | Buy |
48,829,460
+764,321
| +2% | +$188M | 0.3% | 57 |
|
|
2022
Q4 | $12.6B | Buy |
48,065,139
+605,628
| +1% | +$162M | 0.34% | 50 |
|
|
2022
Q3 | $10.7B | Buy |
47,459,511
+1,310,894
| +3% | +$318M | 0.31% | 51 |
|
|
2022
Q2 | $11.2B | Sell |
46,148,617
-1,180,428
| -2% | -$289M | 0.32% | 54 |
|
|
2022
Q1 | $11.4B | Buy |
47,329,045
+668,036
| +1% | +$153M | 0.27% | 62 |
|
|
2021
Q4 | $10.5B | Sell |
46,661,009
-136,233
| -0.3% | -$28.8M | 0.24% | 68 |
|
|
2021
Q3 | $9.95B | Sell |
46,797,242
-313,630
| -0.7% | -$72.2M | 0.25% | 69 |
|
|
2021
Q2 | $11.5B | Sell |
47,110,872
-95,032
| -0.2% | -$23.4M | 0.29% | 60 |
|
|
2021
Q1 | $11.7B | Sell |
47,205,904
-21,325
| -0% | -$5.09M | 0.32% | 55 |
|
|
2020
Q4 | $10.9B | Sell |
47,227,229
-709,831
| -1% | -$164M | 0.32% | 55 |
|
|
2020
Q3 | $12.2B | Sell |
47,937,060
-929,108
| -2% | -$230M | 0.4% | 46 |
|
|
2020
Q2 | $11.5B | Sell |
48,866,168
-778,987
| -2% | -$178M | 0.41% | 42 |
|
|
2020
Q1 | $10.1B | Buy |
49,645,155
+1,173,630
| +2% | +$256M | 0.43% | 41 |
|
|
2019
Q4 | $11.7B | Buy |
48,471,525
+131,051
| +0.3% | +$28.9M | 0.4% | 40 |
|
|
2019
Q3 | $9.35B | Sell |
48,340,474
-631,886
| -1% | -$121M | 0.35% | 48 |
|
|
2019
Q2 | $9.02B | Sell |
48,972,360
-420,293
| -0.9% | -$75.3M | 0.34% | 48 |
|
|
2019
Q1 | $9.38B | Sell |
49,392,653
-526,576
| -1% | -$101M | 0.37% | 47 |
|
|
2018
Q4 | $9.72B | Buy |
49,919,229
+1,017,301
| +2% | +$198M | 0.44% | 36 |
|
|
2018
Q3 | $10.1B | Sell |
48,901,928
-432,415
| -0.9% | -$85.2M | 0.4% | 42 |
|
|
2018
Q2 | $9.11B | Buy |
49,334,343
+241,551
| +0.5% | +$42.7M | 0.38% | 43 |
|
|
2018
Q1 | $8.37B | Sell |
49,092,792
-3,242,017
| -6% | -$595M | 0.37% | 44 |
|
|
2017
Q4 | $9.1B | Sell |
52,334,809
-176,389
| -0.3% | -$31.2M | 0.4% | 41 |
|
|
2017
Q3 | $9.79B | Buy |
52,511,198
+364,263
| +0.7% | +$64.5M | 0.46% | 36 |
|
|
2017
Q2 | $8.98B | Buy |
52,146,935
+489,720
| +0.9% | +$79.7M | 0.44% | 36 |
|
|
2017
Q1 | $8.48B | Buy |
51,657,215
+3,560,566
| +7% | +$592M | 0.44% | 35 |
|
|
2016
Q4 | $7.03B | Buy |
48,096,649
+542,632
| +1% | +$81.7M | 0.39% | 39 |
|
|
2016
Q3 | $7.93B | Buy |
47,554,017
+874,941
| +2% | +$148M | 0.47% | 35 |
|
|
2016
Q2 | $7.1B | Buy |
46,679,076
+673,247
| +1% | +$105M | 0.44% | 39 |
|
|
2016
Q1 | $6.9B | Buy |
46,005,829
+1,089,044
| +2% | +$162M | 0.45% | 39 |
|
|
2015
Q4 | $7.29B | Buy |
44,916,785
+953,984
| +2% | +$150M | 0.49% | 33 |
|
|
2015
Q3 | $6.08B | Buy |
43,962,801
+579,660
| +1% | +$91.4M | 0.44% | 38 |
|
|
2015
Q2 | $6.66B | Buy |
43,383,141
+772,602
| +2% | +$124M | 0.45% | 37 |
|
|
2015
Q1 | $6.81B | Buy |
42,610,539
+1,692,531
| +4% | +$267M | 0.46% | 35 |
|
|
2014
Q4 | $6.52B | Buy |
40,918,008
+1,380,240
| +3% | +$215M | 0.47% | 36 |
|
|
2014
Q3 | $5.55B | Buy |
39,537,768
+962,927
| +2% | +$126M | 0.43% | 36 |
|
|
2014
Q2 | $4.57B | Buy |
38,574,841
+578,934
| +2% | +$67M | 0.36% | 45 |
|
|
2014
Q1 | $4.69B | Buy |
37,995,907
+1,077,538
| +3% | +$131M | 0.39% | 40 |
|
|
2013
Q4 | $4.21B | Buy |
36,918,369
+537,915
| +1% | +$61.2M | 0.37% | 46 |
|
|
2013
Q3 | $4.07B | Buy |
36,380,454
+755,914
| +2% | +$82M | 0.4% | 41 |
|
|
2013
Q2 | $3.51B | Buy |
+35,624,540
| New | +$3.7B | 0.37% | 42 |
|
Other funds holding AMGN
Vanguard Group's AMGN Position: Q4 2025 in Review
Vanguard Group increased its Amgen (AMGN) stake by 1.8% in Q4 2025, buying an estimated $305M and bringing the position to 54,838,826 shares worth $17.9B. The position accounts for 0.26% of the portfolio, ranked #56.
Vanguard Group first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Vanguard Group held 54,838,826 shares of Amgen worth $17.9B as of Q4 2025.
- Vanguard Group bought 961,975 Amgen shares in Q4 2025, an estimated $305M.
- Amgen made up 0.26% of Vanguard Group's portfolio in Q4 2025, its #56 holding.
- Vanguard Group first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.